

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sequestering of metal ion (GO:0051238) | 8.78444188 |
| 2 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 8.62642947 |
| 3 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 8.62642947 |
| 4 | response to fungus (GO:0009620) | 7.96097088 |
| 5 | response to peptidoglycan (GO:0032494) | 7.88769129 |
| 6 | respiratory burst (GO:0045730) | 6.82833991 |
| 7 | cellular extravasation (GO:0045123) | 6.63767916 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 6.53076275 |
| 9 | killing of cells of other organism (GO:0031640) | 6.52108600 |
| 10 | disruption of cells of other organism (GO:0044364) | 6.52108600 |
| 11 | chronic inflammatory response (GO:0002544) | 6.45606973 |
| 12 | neutrophil mediated immunity (GO:0002446) | 6.19764025 |
| 13 | neutrophil activation (GO:0042119) | 5.79094261 |
| 14 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.76605571 |
| 15 | macrophage differentiation (GO:0030225) | 5.66898129 |
| 16 | detection of bacterium (GO:0016045) | 5.64769350 |
| 17 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.59268230 |
| 18 | neutrophil chemotaxis (GO:0030593) | 5.50983145 |
| 19 | neutrophil migration (GO:1990266) | 5.36483255 |
| 20 | detection of other organism (GO:0098543) | 5.29977055 |
| 21 | granulocyte activation (GO:0036230) | 5.22102266 |
| 22 | superoxide anion generation (GO:0042554) | 5.13439483 |
| 23 | negative regulation of cell killing (GO:0031342) | 5.11915333 |
| 24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.11915333 |
| 25 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 5.11729237 |
| 26 | hydrogen peroxide biosynthetic process (GO:0050665) | 5.09807346 |
| 27 | positive regulation of mast cell activation (GO:0033005) | 5.06992404 |
| 28 | phagosome maturation (GO:0090382) | 4.95286918 |
| 29 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.92904145 |
| 30 | response to host immune response (GO:0052572) | 4.92904145 |
| 31 | regulation of leukocyte degranulation (GO:0043300) | 4.88035740 |
| 32 | granulocyte migration (GO:0097530) | 4.81331716 |
| 33 | reactive oxygen species biosynthetic process (GO:1903409) | 4.68504230 |
| 34 | innate immune response in mucosa (GO:0002227) | 4.68377227 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.67390939 |
| 36 | myeloid leukocyte mediated immunity (GO:0002444) | 4.65185579 |
| 37 | granulocyte chemotaxis (GO:0071621) | 4.64078205 |
| 38 | mucosal immune response (GO:0002385) | 4.63005243 |
| 39 | mast cell activation (GO:0045576) | 4.60855190 |
| 40 | response to host (GO:0075136) | 4.54210778 |
| 41 | response to host defenses (GO:0052200) | 4.54210778 |
| 42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.54210778 |
| 43 | antibacterial humoral response (GO:0019731) | 4.51534959 |
| 44 | regulation of regulated secretory pathway (GO:1903305) | 4.49751507 |
| 45 | antimicrobial humoral response (GO:0019730) | 4.46642186 |
| 46 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.42563245 |
| 47 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.37714866 |
| 48 | positive regulation of mast cell degranulation (GO:0043306) | 4.37284967 |
| 49 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.37284967 |
| 50 | organ or tissue specific immune response (GO:0002251) | 4.37199317 |
| 51 | regulation of mast cell activation (GO:0033003) | 4.36355229 |
| 52 | pentose-phosphate shunt (GO:0006098) | 4.33662501 |
| 53 | macrophage activation involved in immune response (GO:0002281) | 4.31407682 |
| 54 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.30272880 |
| 55 | leukocyte cell-cell adhesion (GO:0007159) | 4.17266711 |
| 56 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.13953004 |
| 57 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.12066249 |
| 58 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.10552389 |
| 59 | regulation of mast cell degranulation (GO:0043304) | 4.10438937 |
| 60 | leukotriene metabolic process (GO:0006691) | 4.07675861 |
| 61 | leukotriene biosynthetic process (GO:0019370) | 4.05954048 |
| 62 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.99128964 |
| 63 | detection of biotic stimulus (GO:0009595) | 3.95298664 |
| 64 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.92220088 |
| 65 | negative regulation of phagocytosis (GO:0050765) | 3.92070550 |
| 66 | folic acid transport (GO:0015884) | 3.91334869 |
| 67 | glucose 6-phosphate metabolic process (GO:0051156) | 3.90578085 |
| 68 | NADPH regeneration (GO:0006740) | 3.86292043 |
| 69 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.85308926 |
| 70 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.73796751 |
| 71 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.72889291 |
| 72 | defense response to Gram-positive bacterium (GO:0050830) | 3.71613181 |
| 73 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.68329814 |
| 74 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.68329814 |
| 75 | positive regulation of osteoblast proliferation (GO:0033690) | 3.65092950 |
| 76 | negative regulation of growth of symbiont in host (GO:0044130) | 3.63326589 |
| 77 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.63326589 |
| 78 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.63326589 |
| 79 | regulation of growth of symbiont in host (GO:0044126) | 3.63326589 |
| 80 | cell killing (GO:0001906) | 3.61221868 |
| 81 | B cell mediated immunity (GO:0019724) | 3.58811122 |
| 82 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.54160370 |
| 83 | myeloid cell activation involved in immune response (GO:0002275) | 3.51347113 |
| 84 | positive regulation of lamellipodium assembly (GO:0010592) | 3.50904068 |
| 85 | myeloid leukocyte migration (GO:0097529) | 3.50076264 |
| 86 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.47761574 |
| 87 | positive regulation of leukocyte degranulation (GO:0043302) | 3.46482500 |
| 88 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.43523880 |
| 89 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.42244551 |
| 90 | monocyte chemotaxis (GO:0002548) | 3.37819517 |
| 91 | adaptation of signaling pathway (GO:0023058) | 3.36090427 |
| 92 | cytokine secretion (GO:0050663) | 3.35758631 |
| 93 | defense response to bacterium (GO:0042742) | 3.35062640 |
| 94 | positive regulation of regulated secretory pathway (GO:1903307) | 3.28569269 |
| 95 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.23331352 |
| 96 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.17660767 |
| 97 | detection of molecule of bacterial origin (GO:0032490) | 3.17032092 |
| 98 | leukocyte degranulation (GO:0043299) | 3.13347701 |
| 99 | citrulline biosynthetic process (GO:0019240) | 3.09598871 |
| 100 | leukocyte mediated cytotoxicity (GO:0001909) | 3.09575340 |
| 101 | actin nucleation (GO:0045010) | 3.08298610 |
| 102 | regulation of gamma-delta T cell activation (GO:0046643) | 3.06308918 |
| 103 | macrophage activation (GO:0042116) | 3.05975130 |
| 104 | type I interferon signaling pathway (GO:0060337) | 3.05596800 |
| 105 | cellular response to type I interferon (GO:0071357) | 3.05596800 |
| 106 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.05329663 |
| 107 | response to zinc ion (GO:0010043) | 3.05281494 |
| 108 | leukocyte chemotaxis (GO:0030595) | 3.04543047 |
| 109 | defense response to protozoan (GO:0042832) | 3.03755149 |
| 110 | microglial cell activation (GO:0001774) | 3.02291568 |
| 111 | response to type I interferon (GO:0034340) | 3.01366818 |
| 112 | germinal center formation (GO:0002467) | 2.97636206 |
| 113 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.97019227 |
| 114 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.97019227 |
| 115 | modulation by symbiont of host immune response (GO:0052553) | 2.97019227 |
| 116 | positive regulation by symbiont of host defense response (GO:0052509) | 2.97019227 |
| 117 | modulation by symbiont of host defense response (GO:0052031) | 2.97019227 |
| 118 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.97019227 |
| 119 | response to bacterium (GO:0009617) | 2.95867588 |
| 120 | myeloid leukocyte activation (GO:0002274) | 2.95229006 |
| 121 | detection of external biotic stimulus (GO:0098581) | 2.95174221 |
| 122 | homotypic cell-cell adhesion (GO:0034109) | 2.93306843 |
| 123 | immunoglobulin mediated immune response (GO:0016064) | 2.91723734 |
| 124 | tooth mineralization (GO:0034505) | 2.91369318 |
| 125 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.89256589 |
| 126 | dendritic cell migration (GO:0036336) | 2.89192600 |
| 127 | negative regulation of interleukin-12 production (GO:0032695) | 2.88460973 |
| 128 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.87472037 |
| 129 | negative regulation of innate immune response (GO:0045824) | 2.85744339 |
| 130 | negative regulation of B cell mediated immunity (GO:0002713) | 2.85448153 |
| 131 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.85448153 |
| 132 | cellular response to interleukin-6 (GO:0071354) | 2.82822046 |
| 133 | negative regulation of interleukin-10 production (GO:0032693) | 2.82062184 |
| 134 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.81732809 |
| 135 | glucose catabolic process (GO:0006007) | 2.81056991 |
| 136 | response to interleukin-15 (GO:0070672) | 2.80887866 |
| 137 | positive regulation of inflammatory response (GO:0050729) | 2.80744337 |
| 138 | positive regulation of lamellipodium organization (GO:1902745) | 2.80552174 |
| 139 | regulation of natural killer cell differentiation (GO:0032823) | 2.79997243 |
| 140 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.79256992 |
| 141 | leukocyte aggregation (GO:0070486) | 12.4886118 |
| 142 | leukocyte migration involved in inflammatory response (GO:0002523) | 12.4386805 |
| 143 | defense response to fungus (GO:0050832) | 10.6780780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 4.99883714 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.66618676 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.47456392 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.16665430 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.68658962 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.64067920 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.60345330 |
| 8 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 3.49352024 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.40706450 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.30254323 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.27009605 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.16958014 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.14299621 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.87780121 |
| 15 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.86575828 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.64670354 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.55382509 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.41051891 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 2.26666515 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.26101832 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.21757478 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 2.20825409 |
| 23 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.19606369 |
| 24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.14181989 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.12359163 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.09415891 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 2.09142351 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 2.01796084 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.95827471 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.94753205 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92311057 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.90892958 |
| 33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.81845347 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80401981 |
| 35 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.79791644 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73277121 |
| 37 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.72328221 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.71440240 |
| 39 | MYC_22102868_ChIP-Seq_BL_Human | 1.68234359 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 1.65212619 |
| 41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.64882083 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62604433 |
| 43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.60539107 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.59997622 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.59265280 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.57854533 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.53859938 |
| 48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.53327914 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51214334 |
| 50 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.50395754 |
| 51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.49331193 |
| 52 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.48087828 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.44377527 |
| 54 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.41885068 |
| 55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.40887789 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40431529 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34598797 |
| 58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33904349 |
| 59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.33801754 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33051621 |
| 61 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.32292058 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31766603 |
| 63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29113294 |
| 64 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29110458 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28710033 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27701694 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27394993 |
| 68 | GATA2_19941826_ChIP-Seq_K562_Human | 1.25858040 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25141002 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24503596 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22796408 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22637183 |
| 73 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.17376470 |
| 74 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17317867 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16957472 |
| 76 | GATA3_26560356_Chip-Seq_TH2_Human | 1.16543466 |
| 77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15848339 |
| 78 | MAF_26560356_Chip-Seq_TH2_Human | 1.15297432 |
| 79 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.14806787 |
| 80 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13730121 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13371597 |
| 82 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12443947 |
| 83 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11666515 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11462124 |
| 85 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10777032 |
| 86 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07638290 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07188132 |
| 88 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07155159 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06567890 |
| 90 | P68_20966046_ChIP-Seq_HELA_Human | 1.06341503 |
| 91 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06040801 |
| 92 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04816492 |
| 93 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.03343993 |
| 94 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03274540 |
| 95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02583391 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02338877 |
| 97 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.02232422 |
| 98 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01588766 |
| 99 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01535032 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01460648 |
| 101 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.00949638 |
| 102 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00717581 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99846325 |
| 104 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99481254 |
| 105 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97974350 |
| 106 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97076388 |
| 107 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96668627 |
| 108 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96518947 |
| 109 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.94270470 |
| 110 | SA1_27219007_Chip-Seq_Bcells_Human | 0.92713426 |
| 111 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.92404087 |
| 112 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90448453 |
| 113 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89491998 |
| 114 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88478230 |
| 115 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.87987885 |
| 116 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.87382355 |
| 117 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86066195 |
| 118 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.85861674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 6.20088311 |
| 2 | MP0003436_decreased_susceptibility_to | 5.43206411 |
| 3 | MP0009278_abnormal_bone_marrow | 4.04545049 |
| 4 | MP0009785_altered_susceptibility_to | 4.02466419 |
| 5 | MP0003183_abnormal_peptide_metabolism | 3.80897972 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 3.57606651 |
| 7 | MP0002419_abnormal_innate_immunity | 3.52085440 |
| 8 | MP0001533_abnormal_skeleton_physiology | 2.80044687 |
| 9 | MP0005167_abnormal_blood-brain_barrier | 2.70314370 |
| 10 | MP0005025_abnormal_response_to | 2.66192267 |
| 11 | MP0006082_CNS_inflammation | 2.63267669 |
| 12 | MP0000343_altered_response_to | 2.41876246 |
| 13 | MP0003724_increased_susceptibility_to | 2.27569892 |
| 14 | MP0002405_respiratory_system_inflammati | 2.20225665 |
| 15 | MP0001851_eye_inflammation | 2.19184954 |
| 16 | MP0001853_heart_inflammation | 2.12509441 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.12031390 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.11913083 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.10465275 |
| 20 | MP0005397_hematopoietic_system_phenotyp | 2.09501306 |
| 21 | MP0001545_abnormal_hematopoietic_system | 2.09501306 |
| 22 | MP0001819_abnormal_immune_cell | 2.01073455 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.01018402 |
| 24 | MP0003075_altered_response_to | 1.99730037 |
| 25 | MP0000465_gastrointestinal_hemorrhage | 1.96292060 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.94522568 |
| 27 | MP0004883_abnormal_blood_vessel | 1.93190670 |
| 28 | MP0000685_abnormal_immune_system | 1.89930059 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.89711701 |
| 30 | MP0001835_abnormal_antigen_presentation | 1.88044370 |
| 31 | MP0000858_altered_metastatic_potential | 1.87458310 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.87206315 |
| 33 | MP0001800_abnormal_humoral_immune | 1.79124410 |
| 34 | MP0009764_decreased_sensitivity_to | 1.72588603 |
| 35 | MP0004264_abnormal_extraembryonic_tissu | 1.71431364 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.70962457 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.68595692 |
| 38 | MP0002723_abnormal_immune_serum | 1.68013898 |
| 39 | MP0001790_abnormal_immune_system | 1.63280872 |
| 40 | MP0005387_immune_system_phenotype | 1.63280872 |
| 41 | MP0005023_abnormal_wound_healing | 1.62051702 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.58378322 |
| 43 | MP0002933_joint_inflammation | 1.49828395 |
| 44 | MP0005076_abnormal_cell_differentiation | 1.45753668 |
| 45 | MP0003566_abnormal_cell_adhesion | 1.45138243 |
| 46 | MP0002277_abnormal_respiratory_mucosa | 1.43383578 |
| 47 | MP0002398_abnormal_bone_marrow | 1.42869010 |
| 48 | MP0000716_abnormal_immune_system | 1.41179070 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.36032666 |
| 50 | MP0003763_abnormal_thymus_physiology | 1.34892872 |
| 51 | MP0002396_abnormal_hematopoietic_system | 1.33492392 |
| 52 | MP0005671_abnormal_response_to | 1.32664681 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.28590600 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 1.28383714 |
| 55 | MP0003279_aneurysm | 1.28273026 |
| 56 | MP0003828_pulmonary_edema | 1.26356715 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.26066501 |
| 58 | MP0000569_abnormal_digit_pigmentation | 1.23669685 |
| 59 | MP0005164_abnormal_response_to | 1.23204404 |
| 60 | MP0003448_altered_tumor_morphology | 1.22256213 |
| 61 | MP0002429_abnormal_blood_cell | 1.20462514 |
| 62 | MP0005390_skeleton_phenotype | 1.19168706 |
| 63 | MP0001663_abnormal_digestive_system | 1.18223228 |
| 64 | MP0004947_skin_inflammation | 1.18054112 |
| 65 | MP0005166_decreased_susceptibility_to | 1.16638042 |
| 66 | MP0008469_abnormal_protein_level | 1.14439392 |
| 67 | MP0001873_stomach_inflammation | 1.12673349 |
| 68 | MP0001958_emphysema | 1.12176729 |
| 69 | MP0000689_abnormal_spleen_morphology | 1.11560085 |
| 70 | MP0002722_abnormal_immune_system | 1.10529668 |
| 71 | MP0005319_abnormal_enzyme/_coenzyme | 1.10127549 |
| 72 | MP0005083_abnormal_biliary_tract | 1.03602836 |
| 73 | MP0001542_abnormal_bone_strength | 1.01350596 |
| 74 | MP0006054_spinal_hemorrhage | 0.99385600 |
| 75 | MP0001664_abnormal_digestion | 0.98986153 |
| 76 | MP0002139_abnormal_hepatobiliary_system | 0.98111506 |
| 77 | MP0000490_abnormal_crypts_of | 0.97982218 |
| 78 | MP0008004_abnormal_stomach_pH | 0.97641310 |
| 79 | MP0000477_abnormal_intestine_morphology | 0.97450682 |
| 80 | MP0005058_abnormal_lysosome_morphology | 0.96141839 |
| 81 | MP0003172_abnormal_lysosome_physiology | 0.92342866 |
| 82 | MP0003693_abnormal_embryo_hatching | 0.88968246 |
| 83 | MP0003453_abnormal_keratinocyte_physiol | 0.88577568 |
| 84 | MP0001765_abnormal_ion_homeostasis | 0.88572538 |
| 85 | MP0003866_abnormal_defecation | 0.86654849 |
| 86 | MP0002132_abnormal_respiratory_system | 0.86083946 |
| 87 | MP0005388_respiratory_system_phenotype | 0.85467893 |
| 88 | MP0002133_abnormal_respiratory_system | 0.85467893 |
| 89 | MP0005085_abnormal_gallbladder_physiolo | 0.84908630 |
| 90 | MP0002928_abnormal_bile_duct | 0.79823786 |
| 91 | MP0003806_abnormal_nucleotide_metabolis | 0.79499738 |
| 92 | MP0005381_digestive/alimentary_phenotyp | 0.78947814 |
| 93 | MP0003690_abnormal_glial_cell | 0.77917300 |
| 94 | MP0000920_abnormal_myelination | 0.77166812 |
| 95 | MP0000470_abnormal_stomach_morphology | 0.76922145 |
| 96 | MP0002166_altered_tumor_susceptibility | 0.75423999 |
| 97 | MP0001764_abnormal_homeostasis | 0.75368784 |
| 98 | MP0005174_abnormal_tail_pigmentation | 0.73327156 |
| 99 | MP0004510_myositis | 0.71510931 |
| 100 | MP0009763_increased_sensitivity_to | 0.71479899 |
| 101 | MP0005451_abnormal_body_composition | 0.68970083 |
| 102 | MP0010352_gastrointestinal_tract_polyps | 0.67895113 |
| 103 | MP0000678_abnormal_parathyroid_gland | 0.67655480 |
| 104 | MP0008260_abnormal_autophagy | 0.67139335 |
| 105 | MP0002282_abnormal_trachea_morphology | 0.66412669 |
| 106 | MP0001849_ear_inflammation | 0.66057198 |
| 107 | MP0000703_abnormal_thymus_morphology | 0.63581659 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.62577101 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.61607376 |
| 110 | MP0000249_abnormal_blood_vessel | 0.61185374 |
| 111 | MP0003638_abnormal_response/metabolism_ | 0.60427297 |
| 112 | MP0005310_abnormal_salivary_gland | 0.59682232 |
| 113 | MP0001216_abnormal_epidermal_layer | 0.58474038 |
| 114 | MP0010234_abnormal_vibrissa_follicle | 0.57483696 |
| 115 | MP0003795_abnormal_bone_structure | 0.56858670 |
| 116 | MP0000604_amyloidosis | 0.56788723 |
| 117 | MP0000747_muscle_weakness | 0.56669397 |
| 118 | MP0002089_abnormal_postnatal_growth/wei | 0.56081246 |
| 119 | MP0003123_paternal_imprinting | 0.55823769 |
| 120 | MP0008874_decreased_physiological_sensi | 0.54342178 |
| 121 | MP0009931_abnormal_skin_appearance | 0.53440183 |
| 122 | MP0004858_abnormal_nervous_system | 0.53330996 |
| 123 | MP0005365_abnormal_bile_salt | 0.52916115 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.51938483 |
| 125 | MP0003045_fibrosis | 0.51148443 |
| 126 | MP0004381_abnormal_hair_follicle | 0.50808062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 8.97834922 |
| 2 | Chronic obstructive pulmonary disease (HP:0006510) | 6.85181894 |
| 3 | Obstructive lung disease (HP:0006536) | 6.85181894 |
| 4 | Abnormality of macrophages (HP:0004311) | 6.50706879 |
| 5 | Gingivitis (HP:0000230) | 6.42184110 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 6.20254351 |
| 7 | Recurrent skin infections (HP:0001581) | 5.09787643 |
| 8 | Cellulitis (HP:0100658) | 4.94496746 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.91024953 |
| 10 | Urticaria (HP:0001025) | 4.90196446 |
| 11 | Stomatitis (HP:0010280) | 4.88034476 |
| 12 | Premature loss of primary teeth (HP:0006323) | 4.05945344 |
| 13 | Meningitis (HP:0001287) | 3.81256299 |
| 14 | Hyperactive renin-angiotensin system (HP:0000841) | 3.81144084 |
| 15 | Abnormal vertebral ossification (HP:0100569) | 3.56487453 |
| 16 | Episodic fever (HP:0001954) | 3.55207751 |
| 17 | Difficulty running (HP:0009046) | 3.54124740 |
| 18 | Myositis (HP:0100614) | 3.44670306 |
| 19 | Papilledema (HP:0001085) | 3.44101546 |
| 20 | Muscle fiber splitting (HP:0003555) | 3.28409807 |
| 21 | Osteomalacia (HP:0002749) | 3.22143477 |
| 22 | Increased connective tissue (HP:0009025) | 3.21348544 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.18017987 |
| 24 | Abnormal platelet volume (HP:0011876) | 3.07772842 |
| 25 | Anorexia (HP:0002039) | 3.02749397 |
| 26 | Periodontitis (HP:0000704) | 2.91855358 |
| 27 | Recurrent pneumonia (HP:0006532) | 2.89226264 |
| 28 | Sepsis (HP:0100806) | 2.84797353 |
| 29 | Metabolic alkalosis (HP:0200114) | 2.77566779 |
| 30 | Osteomyelitis (HP:0002754) | 2.76134277 |
| 31 | Malnutrition (HP:0004395) | 2.70327832 |
| 32 | Abnormality of the costochondral junction (HP:0000919) | 2.70070202 |
| 33 | Vertebral clefting (HP:0008428) | 2.68570510 |
| 34 | Pustule (HP:0200039) | 2.66322936 |
| 35 | Colitis (HP:0002583) | 2.62947416 |
| 36 | Flat acetabular roof (HP:0003180) | 2.62023253 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.61690411 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.61690411 |
| 39 | Increased mean platelet volume (HP:0011877) | 2.59499764 |
| 40 | Pathologic fracture (HP:0002756) | 2.58500555 |
| 41 | Hepatosplenomegaly (HP:0001433) | 2.52697296 |
| 42 | Orchitis (HP:0100796) | 2.51801995 |
| 43 | Skin ulcer (HP:0200042) | 2.50353577 |
| 44 | Widely patent fontanelles and sutures (HP:0004492) | 2.49031433 |
| 45 | Muscle fibrillation (HP:0010546) | 2.41378684 |
| 46 | Abnormality of renin-angiotensin system (HP:0000847) | 2.39390593 |
| 47 | Decreased circulating renin level (HP:0003351) | 2.36244530 |
| 48 | Increased IgM level (HP:0003496) | 2.36006909 |
| 49 | Panhypogammaglobulinemia (HP:0003139) | 2.35679529 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.33203321 |
| 51 | Abnormal foot bone ossification (HP:0010675) | 2.31164950 |
| 52 | IgM deficiency (HP:0002850) | 2.30811823 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 2.30572193 |
| 54 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.30260919 |
| 55 | Recurrent viral infections (HP:0004429) | 2.29313398 |
| 56 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.28620885 |
| 57 | Recurrent lower respiratory tract infections (HP:0002783) | 2.28591339 |
| 58 | Keratoconjunctivitis sicca (HP:0001097) | 2.26254293 |
| 59 | Increased serum ferritin (HP:0003281) | 2.25444811 |
| 60 | Slender build (HP:0001533) | 2.24316624 |
| 61 | Hyporeflexia of lower limbs (HP:0002600) | 2.18814697 |
| 62 | Hypermelanotic macule (HP:0001034) | 2.17310997 |
| 63 | Petechiae (HP:0000967) | 2.15661687 |
| 64 | Leukocytosis (HP:0001974) | 2.14625700 |
| 65 | Hemorrhage of the eye (HP:0011885) | 2.14277277 |
| 66 | Short femoral neck (HP:0100864) | 2.13254534 |
| 67 | Purpura (HP:0000979) | 2.12669280 |
| 68 | Vacuolated lymphocytes (HP:0001922) | 2.12441228 |
| 69 | Hypergammaglobulinemia (HP:0010702) | 2.12326409 |
| 70 | Thickened calvaria (HP:0002684) | 2.12143374 |
| 71 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.10880468 |
| 72 | Short 4th metacarpal (HP:0010044) | 2.10880468 |
| 73 | Increased variability in muscle fiber diameter (HP:0003557) | 2.10721503 |
| 74 | Cheilitis (HP:0100825) | 2.09385576 |
| 75 | Increased IgE level (HP:0003212) | 2.08577108 |
| 76 | Amyloidosis (HP:0011034) | 2.08402252 |
| 77 | Chromsome breakage (HP:0040012) | 2.07761965 |
| 78 | Granulocytopenia (HP:0001913) | 2.07719565 |
| 79 | Gingival bleeding (HP:0000225) | 2.07245852 |
| 80 | Hypochromic anemia (HP:0001931) | 2.05672637 |
| 81 | Epistaxis (HP:0000421) | 2.04094485 |
| 82 | Keratoconjunctivitis (HP:0001096) | 2.02776120 |
| 83 | Metaphyseal irregularity (HP:0003025) | 2.00165382 |
| 84 | Eczematoid dermatitis (HP:0000976) | 10.9381861 |
| 85 | Recurrent abscess formation (HP:0002722) | 10.3904568 |
| 86 | Recurrent gram-negative bacterial infections (HP:0005420) | 10.0367820 |
| 87 | Systemic lupus erythematosus (HP:0002725) | 1.98354270 |
| 88 | Prolonged bleeding time (HP:0003010) | 1.98227947 |
| 89 | Cutaneous photosensitivity (HP:0000992) | 1.97864086 |
| 90 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.97050047 |
| 91 | Abnormality of chloride homeostasis (HP:0011422) | 1.96331699 |
| 92 | Gastrointestinal stroma tumor (HP:0100723) | 1.95976167 |
| 93 | Vasculitis (HP:0002633) | 1.95904044 |
| 94 | Hemoptysis (HP:0002105) | 1.95452955 |
| 95 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.93054860 |
| 96 | Agammaglobulinemia (HP:0004432) | 1.90757946 |
| 97 | Hypertriglyceridemia (HP:0002155) | 1.90586566 |
| 98 | Pyloric stenosis (HP:0002021) | 1.90111818 |
| 99 | Difficulty climbing stairs (HP:0003551) | 1.89802456 |
| 100 | Chest pain (HP:0100749) | 1.87667973 |
| 101 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.85438841 |
| 102 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.85216444 |
| 103 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83997490 |
| 104 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.81898086 |
| 105 | Autoimmune thrombocytopenia (HP:0001973) | 1.81855712 |
| 106 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.80269324 |
| 107 | Inflammation of the large intestine (HP:0002037) | 1.79946059 |
| 108 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.79908844 |
| 109 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.79908844 |
| 110 | Abnormality of glycolipid metabolism (HP:0010969) | 1.79908844 |
| 111 | Abnormality of iron homeostasis (HP:0011031) | 1.77222376 |
| 112 | Peritonitis (HP:0002586) | 1.76478021 |
| 113 | Absent frontal sinuses (HP:0002688) | 1.73304854 |
| 114 | Encephalitis (HP:0002383) | 1.73138323 |
| 115 | Retrobulbar optic neuritis (HP:0100654) | 1.70111889 |
| 116 | Optic neuritis (HP:0100653) | 1.70111889 |
| 117 | Gastrointestinal inflammation (HP:0004386) | 1.68961854 |
| 118 | Pulmonary embolism (HP:0002204) | 1.68689415 |
| 119 | Mesomelia (HP:0003027) | 1.65713530 |
| 120 | Thyroiditis (HP:0100646) | 1.65603200 |
| 121 | Duplicated collecting system (HP:0000081) | 1.63992460 |
| 122 | Verrucae (HP:0200043) | 1.63134901 |
| 123 | Papilloma (HP:0012740) | 1.63134901 |
| 124 | Recurrent sinusitis (HP:0011108) | 1.61835358 |
| 125 | Nonimmune hydrops fetalis (HP:0001790) | 1.60298910 |
| 126 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.60146375 |
| 127 | Increased cerebral lipofuscin (HP:0011813) | 1.60126576 |
| 128 | Ectopic kidney (HP:0000086) | 1.59131271 |
| 129 | Metaphyseal cupping (HP:0003021) | 1.59120243 |
| 130 | Myelodysplasia (HP:0002863) | 1.58068582 |
| 131 | Tracheoesophageal fistula (HP:0002575) | 1.58067983 |
| 132 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.58037542 |
| 133 | Lymphopenia (HP:0001888) | 1.57753802 |
| 134 | Abnormality of the common coagulation pathway (HP:0010990) | 1.57737339 |
| 135 | Eosinophilia (HP:0001880) | 1.57670647 |
| 136 | Chronic otitis media (HP:0000389) | 1.53583362 |
| 137 | Increased density of long bones (HP:0006392) | 1.52270881 |
| 138 | Long clavicles (HP:0000890) | 1.51359872 |
| 139 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.48073019 |
| 140 | Abnormality of T cell physiology (HP:0011840) | 1.47927211 |
| 141 | Persistence of primary teeth (HP:0006335) | 1.46364305 |
| 142 | Gastrointestinal infarctions (HP:0005244) | 1.44782566 |
| 143 | Abnormality of the pleura (HP:0002103) | 1.44257755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 5.76859732 |
| 2 | EPHB1 | 3.67133685 |
| 3 | RIPK4 | 3.23639168 |
| 4 | FGR | 3.07363783 |
| 5 | TRPM7 | 3.07098018 |
| 6 | BLK | 3.06922427 |
| 7 | CSK | 2.98904691 |
| 8 | TESK2 | 2.72111869 |
| 9 | CLK1 | 2.65199073 |
| 10 | GRK6 | 2.63526877 |
| 11 | FES | 2.60805041 |
| 12 | ERBB3 | 2.45269235 |
| 13 | ERN1 | 2.40089189 |
| 14 | MAP3K9 | 2.40066979 |
| 15 | MAP3K12 | 2.28473155 |
| 16 | BTK | 2.21419387 |
| 17 | STK10 | 2.19104967 |
| 18 | MAP2K3 | 2.11734578 |
| 19 | TESK1 | 2.10987348 |
| 20 | TTN | 2.04322582 |
| 21 | MAP4K1 | 1.85467588 |
| 22 | HCK | 1.79300519 |
| 23 | PRPF4B | 1.69186610 |
| 24 | PIK3CA | 1.65210854 |
| 25 | TRIB3 | 1.61729127 |
| 26 | TEC | 1.56743224 |
| 27 | PRKG2 | 1.52989072 |
| 28 | JAK3 | 1.49288676 |
| 29 | LRRK2 | 1.46124026 |
| 30 | KSR2 | 1.37867113 |
| 31 | PAK4 | 1.34561827 |
| 32 | PTK6 | 1.31643485 |
| 33 | SIK3 | 1.31586093 |
| 34 | MAP2K4 | 1.23967995 |
| 35 | ALK | 1.21662917 |
| 36 | PRKD2 | 1.20295371 |
| 37 | BRSK2 | 1.18491812 |
| 38 | TAOK1 | 1.16577037 |
| 39 | KDR | 1.16195689 |
| 40 | PTK2 | 1.14355123 |
| 41 | LIMK1 | 1.11210161 |
| 42 | MAP3K3 | 1.09701923 |
| 43 | ZAP70 | 1.04843859 |
| 44 | TAOK2 | 1.01256876 |
| 45 | MAP3K11 | 1.00598332 |
| 46 | MARK2 | 0.97811217 |
| 47 | MAP3K5 | 0.94561928 |
| 48 | MAPK4 | 0.93496765 |
| 49 | CDC42BPA | 0.93005930 |
| 50 | IKBKE | 0.91212930 |
| 51 | SMG1 | 0.90521989 |
| 52 | CSF1R | 0.89783063 |
| 53 | MAP2K6 | 0.86193634 |
| 54 | ITK | 0.86084359 |
| 55 | NEK2 | 0.85624718 |
| 56 | ACVR1B | 0.83339986 |
| 57 | TYK2 | 0.80893469 |
| 58 | SYK | 0.80454361 |
| 59 | PKN2 | 0.77095404 |
| 60 | LMTK2 | 0.76763758 |
| 61 | RET | 0.76002761 |
| 62 | WEE1 | 0.71184544 |
| 63 | MAP3K8 | 0.69670780 |
| 64 | JAK1 | 0.68865678 |
| 65 | TXK | 0.66890393 |
| 66 | PTK2B | 0.65789895 |
| 67 | MAP3K13 | 0.65522084 |
| 68 | STK4 | 0.64809356 |
| 69 | LYN | 0.64355219 |
| 70 | SIK1 | 0.61322628 |
| 71 | FYN | 0.59715491 |
| 72 | MAP3K7 | 0.59429701 |
| 73 | PIM1 | 0.59212870 |
| 74 | CDC7 | 0.58233810 |
| 75 | STK11 | 0.57555658 |
| 76 | RIPK1 | 0.57392688 |
| 77 | EPHA2 | 0.56682273 |
| 78 | MAP3K14 | 0.56512456 |
| 79 | MAP3K1 | 0.56148959 |
| 80 | FRK | 0.56020888 |
| 81 | BMX | 0.55587023 |
| 82 | PRKCD | 0.55412867 |
| 83 | CDK19 | 0.55064580 |
| 84 | RPS6KL1 | 0.53667596 |
| 85 | RPS6KC1 | 0.53667596 |
| 86 | PRKCH | 0.53524266 |
| 87 | MAPKAPK2 | 0.52836420 |
| 88 | JAK2 | 0.52163100 |
| 89 | TNK2 | 0.52035914 |
| 90 | NEK9 | 0.50275330 |
| 91 | GRK1 | 0.50128079 |
| 92 | RPS6KA6 | 0.50019192 |
| 93 | LCK | 0.49365781 |
| 94 | DMPK | 0.49310690 |
| 95 | MST1R | 0.48255559 |
| 96 | MATK | 0.47206049 |
| 97 | MAPK12 | 0.46293781 |
| 98 | PDPK1 | 0.45902513 |
| 99 | IKBKB | 0.45343291 |
| 100 | MARK3 | 0.44628533 |
| 101 | FGFR3 | 0.44353809 |
| 102 | ADRBK1 | 0.44134919 |
| 103 | EPHA3 | 0.42869672 |
| 104 | RPS6KA2 | 0.42212298 |
| 105 | PDK1 | 0.41710119 |
| 106 | CCNB1 | 0.40826098 |
| 107 | SGK3 | 0.40036281 |
| 108 | BMPR2 | 0.37760354 |
| 109 | DAPK2 | 0.35314311 |
| 110 | PRKCZ | 0.34236387 |
| 111 | MAP2K2 | 0.34119845 |
| 112 | PRKAA2 | 0.33308095 |
| 113 | FGFR4 | 0.33064220 |
| 114 | DYRK1B | 0.32238293 |
| 115 | IRAK1 | 0.32232120 |
| 116 | TGFBR2 | 0.31466121 |
| 117 | EGFR | 0.31406241 |
| 118 | MYLK | 0.30369627 |
| 119 | MAPK7 | 0.29792409 |
| 120 | MAP3K6 | 0.29409629 |
| 121 | ABL1 | 0.28764687 |
| 122 | TBK1 | 0.28552133 |
| 123 | PRKD1 | 0.28157257 |
| 124 | RPS6KA1 | 0.27546403 |
| 125 | MAPK11 | 0.26578767 |
| 126 | BRSK1 | 0.25973158 |
| 127 | PIK3CG | 0.25970742 |
| 128 | NEK1 | 0.25652350 |
| 129 | STK38 | 0.25587640 |
| 130 | YES1 | 0.24843159 |
| 131 | KIT | 0.23270871 |
| 132 | TAOK3 | 0.22659445 |
| 133 | IRAK3 | 0.22089835 |
| 134 | FGFR1 | 0.21015190 |
| 135 | SIK2 | 0.20534463 |
| 136 | MAP3K2 | 0.19980066 |
| 137 | PRKACB | 0.19266731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 4.30883652 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.57816369 |
| 3 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 3.38833647 |
| 4 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.83673366 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.73088249 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.55602790 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.49460700 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.13728993 |
| 9 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 2.06669585 |
| 10 | Shigellosis_Homo sapiens_hsa05131 | 2.01588732 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 2.00765557 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.97475386 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.88169774 |
| 14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.87273006 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.72606271 |
| 16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.72221598 |
| 17 | Platelet activation_Homo sapiens_hsa04611 | 1.66725439 |
| 18 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.65552378 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.53239271 |
| 20 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.52352071 |
| 21 | Phagosome_Homo sapiens_hsa04145 | 1.51087598 |
| 22 | Galactose metabolism_Homo sapiens_hsa00052 | 1.50216718 |
| 23 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.48315473 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47419989 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.47158816 |
| 26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.46633360 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.43020937 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.42469804 |
| 29 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.36325192 |
| 30 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.35618785 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.33608197 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.33265153 |
| 33 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.32499377 |
| 34 | Bladder cancer_Homo sapiens_hsa05219 | 1.28308223 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28279500 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26756079 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.25502284 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.25046883 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.22045732 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.20902799 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17413013 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.16479487 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13234877 |
| 44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.12861485 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.07646777 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06988916 |
| 47 | Amoebiasis_Homo sapiens_hsa05146 | 1.06630730 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.03412381 |
| 49 | Insulin resistance_Homo sapiens_hsa04931 | 0.98519095 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.97744427 |
| 51 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.96258977 |
| 52 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.95651737 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94694632 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93911904 |
| 55 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.93077552 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.91597090 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89513095 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.88036753 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86248382 |
| 60 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.85973816 |
| 61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.83121124 |
| 62 | Malaria_Homo sapiens_hsa05144 | 0.82892082 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82235479 |
| 64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81867571 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81049011 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79998305 |
| 67 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.79768398 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.78054317 |
| 69 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.76408128 |
| 70 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.73489521 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73305437 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.71197791 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70430043 |
| 74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.69228462 |
| 75 | Influenza A_Homo sapiens_hsa05164 | 0.68509389 |
| 76 | Apoptosis_Homo sapiens_hsa04210 | 0.68266560 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67781818 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67296713 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65744571 |
| 80 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65547664 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63260233 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62431170 |
| 83 | Adherens junction_Homo sapiens_hsa04520 | 0.60627013 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.60299928 |
| 85 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60101891 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59613985 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58488147 |
| 88 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.58155781 |
| 89 | Measles_Homo sapiens_hsa05162 | 0.57161529 |
| 90 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53914257 |
| 91 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53364021 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52705766 |
| 93 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52396001 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.52077286 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51760559 |
| 96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.51198549 |
| 97 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.51126326 |
| 98 | Focal adhesion_Homo sapiens_hsa04510 | 0.50002470 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49396060 |
| 100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49039168 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49023968 |
| 102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.48854676 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48001339 |
| 104 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47947739 |
| 105 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47659462 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47389215 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47250830 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45769845 |
| 109 | Glioma_Homo sapiens_hsa05214 | 0.45729444 |
| 110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45405966 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45348381 |
| 112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43331642 |
| 113 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42985749 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42334352 |
| 115 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42219358 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42198264 |
| 117 | Lysosome_Homo sapiens_hsa04142 | 0.42187253 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | 0.39059016 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38563457 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38515407 |
| 121 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38454473 |
| 122 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.37701770 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37327590 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35692229 |
| 125 | Salivary secretion_Homo sapiens_hsa04970 | 0.34578570 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34370642 |
| 127 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.33592103 |
| 128 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32015156 |
| 129 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31699864 |
| 130 | Pathways in cancer_Homo sapiens_hsa05200 | 0.31279453 |
| 131 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29931711 |

